Market News
Stay updated with the latest market trends, earnings, and economic indicators.
Breakout stocks to buy or sell: Sumeet Bagadia recommends five shares to buy today — 11 March 2026
Breakout stocks to buy or sell: Sumeet Bagadia recommends five shares to buy today — Anupam Rasayan India, Schneider Electric Infrastructure, MM Forgings, Godawari Power and Ispat, and Aurobindo Pharma.
Vaishali Parekh Suggests 3 Intraday Stocks to Buy Today: Paytm, Aurobindo Pharma, DCX Systems - Meyka
Vaishali Parekh Suggests 3 Intraday Stocks to Buy Today: Paytm, Aurobindo Pharma, DCX SystemsMeyka
Buy or sell: Amid US-Iran war, Vaishali Parekh recommends three intraday stocks to buy today
Buy or sell: Vaishali Parekh recommends three intraday stocks to buy today — Paytm, Aurobindo Pharma, and DCX System
Market Trading Guide: Apollo Pipes among 3 stock recommendations for Tuesday
Sensex and Nifty plunged nearly 2% as rising crude oil prices, weak global cues and escalating West Asia tensions triggered heavy selling. Foreign fund outflows and a weaker rupee added pressure. Analysts recommend Apollo Pipes, Aurobindo Pharma and Tata Steel for potential short-term gains.
Aurobindo Pharma launches Pomalidomide capsules in US market
Aurobindo Pharma informed that its wholly-owned subsidiary, Eugia Pharma Specialities, has launched Pomalidomide Capsules in strengths of 1 mg, 2 mg, 3 mg, and 4 mg in the U.S. market.
Aurobindo Pharma arm receives 4 observations after US FDA inspection
Aurobindo Pharma has informed that the US FDA inspection concluded with four observations at a formulation manufacturing facility of its wholly owned subsidiary, Eugia Pharma Specialities, in Telangana.
Aurobindo Pharma arm Eugia Pharma unit-I inspected by US FDA; 4 observations reported
Shares of Aurobindo Pharma Ltd ended at ₹1,220.70, down by ₹1.30, or 0.11%, on the BSE.
Aurobindo Pharma's P Sarath Chandra Reddy acquitted in Delhi Liquor Scam case
According to an Indian Express Report dated March 25, 2024, a Delhi court had allowed Reddy to turn approver in this case and had also granted him a pardon.
Aurobindo Pharma shares gain after Eugia wins USFDA approval for liver transplant drug
The approval has been granted to Eugia Unit-I, with the product launch expected in the first quarter of FY27.
Elara Securities bets on pharma revival; picks Zydus Life, Sun Pharma, Aurobindo Pharma
Bino Pathiparampil, Head of Research at Elara Securities believes the broader pharma space is entering a more favourable phase as pricing concerns and regulatory worries ease while currency movements provide an additional boost.
Mankind Pharma among 4 stocks showing bullish RSI upswing
Four Nifty200 stocks, including Mankind Pharma and Aurobindo Pharma, signalled strengthening momentum on February 25 as their RSI crossed above the 50 mark. The RSI Trending Up scan highlights improving price strength, often interpreted by traders as a potential buying opportunity amid sustained upward movement.
Penicillin shot: Will Aurobindo Pharma’s audacious bet rejuvenate antibiotic production in India?
In a coastal plant brimming with fermenters, Aurobindo Pharma is attempting what few thought possible again: the large-scale manufacture of penicillin in India. With government backing, the company is challenging China’s dominance over the basic antibiotic ingredient.